Rocket Pharmaceuticals (RCKT) News Today $11.56 +0.21 (+1.85%) (As of 12/20/2024 05:40 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Rocket Pharmaceuticals (NASDAQ:RCKT) Reaches New 1-Year Low - What's Next?Rocket Pharmaceuticals (NASDAQ:RCKT) Hits New 1-Year Low - Time to Sell?December 19 at 11:02 AM | marketbeat.comFranklin Resources Inc. Reduces Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Franklin Resources Inc. decreased its position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 7.7% during the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 1,730,344 shares of the biotechnology company's stock after selling 143,345 shares during tDecember 19 at 5:15 AM | marketbeat.comHead to Head Review: InMed Pharmaceuticals (NASDAQ:INM) vs. Rocket Pharmaceuticals (NASDAQ:RCKT)December 19 at 4:41 AM | americanbankingnews.comState Street Corp Buys 322,156 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)State Street Corp lifted its stake in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 11.6% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,102,022 shares of the biotechnology company's stock after pDecember 19 at 3:33 AM | marketbeat.comJefferies Initiates Coverage of Rocket Pharmaceuticals (RCKT) with Buy RecommendationDecember 18 at 5:36 PM | msn.comRocket Pharmaceuticals Stock Soars as Jefferies Initiates Coverage at 'Buy'December 18 at 3:00 PM | investopedia.comRocket Pharmaceuticals (NASDAQ:RCKT) Shares Gap Up - What's Next?Rocket Pharmaceuticals (NASDAQ:RCKT) Shares Gap Up - Still a Buy?December 18 at 10:55 AM | marketbeat.comJefferies Financial Group Initiates Coverage on Rocket Pharmaceuticals (NASDAQ:RCKT)Jefferies Financial Group started coverage on shares of Rocket Pharmaceuticals in a report on Wednesday. They set a "buy" rating and a $29.00 price objective for the company.December 18 at 8:07 AM | marketbeat.comEquities Analysts Offer Predictions for RCKT FY2024 EarningsDecember 17, 2024 | americanbankingnews.comSynovus Financial Corp Trims Stock Holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Synovus Financial Corp reduced its holdings in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 43.2% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 95,504 shares of the biotechnolDecember 16, 2024 | marketbeat.comFY2024 Earnings Estimate for RCKT Issued By Leerink PartnrsRocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) - Stock analysts at Leerink Partnrs upped their FY2024 EPS estimates for shares of Rocket Pharmaceuticals in a report issued on Wednesday, December 11th. Leerink Partnrs analyst M. Foroohar now forecasts that the biotechnology company willDecember 16, 2024 | marketbeat.comRocket Pharmaceuticals (NASDAQ:RCKT) Sets New 12-Month Low - Here's WhyRocket Pharmaceuticals (NASDAQ:RCKT) Hits New 52-Week Low - Time to Sell?December 13, 2024 | marketbeat.comRocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Shares Sold by Fmr LLCFmr LLC lessened its holdings in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 19.6% in the third quarter, according to its most recent filing with the SEC. The firm owned 465,456 shares of the biotechnology company's stock after selling 113,823 shares during the quarter. FmDecember 12, 2024 | marketbeat.comRocket Pharmaceuticals 13.2M share Spot Secondary priced at $12.50December 11, 2024 | markets.businessinsider.comPoint72 Asset Management L.P. Invests $888,000 in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Point72 Asset Management L.P. purchased a new stake in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 48,096 shares of the biotechnology company's stDecember 11, 2024 | marketbeat.comFrazier Life Sciences Management L.P. Lowers Stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Frazier Life Sciences Management L.P. cut its position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 4.8% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,485,630 sharDecember 10, 2024 | marketbeat.comRocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Shares Purchased by Wellington Management Group LLPWellington Management Group LLP raised its holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 22.8% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 11,242,December 9, 2024 | marketbeat.comJanus Henderson Group PLC Has $35.06 Million Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Janus Henderson Group PLC decreased its position in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 35.0% during the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,897,340 shares of the biotechnology company'sDecember 7, 2024 | marketbeat.comErste Asset Management GmbH Purchases New Stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Erste Asset Management GmbH purchased a new stake in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 44,700 shares of the biotechnology company's stock, valued at approximaDecember 4, 2024 | marketbeat.comWalleye Capital LLC Acquires Shares of 138,403 Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Walleye Capital LLC acquired a new position in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) in the 3rd quarter, according to its most recent disclosure with the SEC. The fund acquired 138,403 shares of the biotechnology company's stock, valued at approximately $2,556,000. WallDecember 4, 2024 | marketbeat.comRocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Given Average Rating of "Moderate Buy" by AnalystsRocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Get Free Report) has earned an average recommendation of "Moderate Buy" from the eleven research firms that are covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold rating and ten have issued a buyDecember 4, 2024 | marketbeat.comBamco Inc. NY Reduces Holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Bamco Inc. NY lessened its position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 9.7% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 884,341 shares of the biotechnology company's stock after selling 94,990 shDecember 3, 2024 | marketbeat.comRocket Pharmaceuticals: Not Bad Valuation But Reflexivity Risks RemainDecember 2, 2024 | seekingalpha.comAcuta Capital Partners LLC Sells 60,370 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Acuta Capital Partners LLC reduced its holdings in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 24.1% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 190,000 shares of the biotechnology comNovember 28, 2024 | marketbeat.com3 Small-Cap Stocks That Are Ready to Rocket Higher (RCKT)With lower interest rates and lower corporate taxes more likely, it's a good time to consider three small-cap stocks that present a buying opportunityNovember 27, 2024 | marketbeat.comRocket Pharmaceuticals to Participate in the 7th Annual Evercore HealthCONx ConferenceNovember 26, 2024 | businesswire.comMartin Wilson Sells 1,175 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) StockNovember 26, 2024 | insidertrades.comWestfield Capital Management Co. LP Grows Stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Westfield Capital Management Co. LP boosted its stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 3.8% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,493,833 shares of the biotechnNovember 24, 2024 | marketbeat.comRocket Pharmaceuticals (NASDAQ:RCKT) Shares Up 6.3% - Time to Buy?Rocket Pharmaceuticals (NASDAQ:RCKT) Trading 6.3% Higher - Should You Buy?November 22, 2024 | marketbeat.comFY2025 Earnings Estimate for RCKT Issued By Leerink PartnrsRocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) - Investment analysts at Leerink Partnrs lifted their FY2025 earnings estimates for shares of Rocket Pharmaceuticals in a research note issued to investors on Monday, November 18th. Leerink Partnrs analyst M. Foroohar now anticipates that tNovember 21, 2024 | marketbeat.comRocket Pharmaceuticals' Gene Therapy Progress Boosts Confidence in Future Developments: AnalystNovember 19, 2024 | benzinga.comPromising Clinical Developments in Rocket Pharmaceuticals Justify Buy Rating and $52 Target PriceNovember 19, 2024 | markets.businessinsider.comTD Cowen Sticks to Their Buy Rating for Rocket Pharmaceuticals (RCKT)November 19, 2024 | markets.businessinsider.comLeerink Partners Issues Pessimistic Forecast for Rocket Pharmaceuticals (NASDAQ:RCKT) Stock PriceLeerink Partners decreased their price target on shares of Rocket Pharmaceuticals from $46.00 to $44.00 and set an "outperform" rating on the stock in a research report on Tuesday.November 19, 2024 | marketbeat.comCantor Fitzgerald Reiterates Overweight Rating for Rocket Pharmaceuticals (NASDAQ:RCKT)Cantor Fitzgerald reissued an "overweight" rating and issued a $65.00 target price on shares of Rocket Pharmaceuticals in a report on Tuesday.November 19, 2024 | marketbeat.comRocket Pharmaceuticals' (RCKT) Buy Rating Reiterated at Needham & Company LLCNeedham & Company LLC reissued a "buy" rating and set a $52.00 price objective on shares of Rocket Pharmaceuticals in a report on Tuesday.November 19, 2024 | marketbeat.comRocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Shares Bought by First Turn Management LLCFirst Turn Management LLC grew its stake in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 10.8% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 621,306 shares of the biotechnology compNovember 19, 2024 | marketbeat.comRocket Pharmaceuticals has not initiated enrollment in Phase 2 RP-L301 studyNovember 19, 2024 | markets.businessinsider.comRocket Pharmaceuticals’ RP-A501 Shows Promising Long-Term Efficacy and Safety in Danon Disease Treatment: Buy Rating AffirmedNovember 19, 2024 | markets.businessinsider.comRocket Pharma Stock Slips Despite New Long-Term Data On Phase-I Study; Retail Sentiment SlidesNovember 18, 2024 | msn.comRocket Pharmaceuticals announces publication of Phase 1 RP-A501 long-term dataNovember 18, 2024 | markets.businessinsider.comRocket Pharmaceuticals (NASDAQ:RCKT) Reaches New 52-Week Low - Here's What HappenedRocket Pharmaceuticals (NASDAQ:RCKT) Reaches New 52-Week Low - Here's WhyNovember 18, 2024 | marketbeat.comScotiabank Sticks to Its Buy Rating for Rocket Pharmaceuticals (RCKT)November 16, 2024 | markets.businessinsider.comChardan Capital Has Strong Forecast for RCKT FY2024 EarningsRocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) - Stock analysts at Chardan Capital increased their FY2024 EPS estimates for Rocket Pharmaceuticals in a research note issued to investors on Monday, November 11th. Chardan Capital analyst Y. Livshits now forecasts that the biotechnology coNovember 14, 2024 | marketbeat.comPrivium Fund Management B.V. Has $5.45 Million Holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Privium Fund Management B.V. raised its position in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 17.5% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 294,800 shares of the biNovember 10, 2024 | marketbeat.comJ.P. Morgan Remains a Buy on Rocket Pharmaceuticals (RCKT)November 9, 2024 | markets.businessinsider.comRocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Given Consensus Rating of "Moderate Buy" by BrokeragesShares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Get Free Report) have been given an average rating of "Moderate Buy" by the ten research firms that are currently covering the firm, Marketbeat reports. One analyst has rated the stock with a hold rating and nine have issued a buy rating on tNovember 9, 2024 | marketbeat.comRocket Pharmaceuticals: Strong Buy Rating Backed by Promising AAV and LV Franchise Developments and Solid Financial PositionNovember 9, 2024 | markets.businessinsider.comRocket Pharmaceuticals (NASDAQ:RCKT) Receives "Buy" Rating from Needham & Company LLCNeedham & Company LLC reiterated a "buy" rating and set a $52.00 target price on shares of Rocket Pharmaceuticals in a research report on Friday.November 8, 2024 | marketbeat.comRocket Pharmaceuticals Reports Third Quarter 2024 Financial Results and Highlights Recent ProgressNovember 7, 2024 | finance.yahoo.com Get Rocket Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RCKT and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now RCKT Media Mentions By Week RCKT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RCKT News Sentiment▼0.690.61▲Average Medical News Sentiment RCKT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RCKT Articles This Week▼157▲RCKT Articles Average Week Get Rocket Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RCKT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies RARE News Today BHVN News Today APLS News Today IMVT News Today SRRK News Today RNA News Today OGN News Today PTCT News Today VRNA News Today RYTM News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RCKT) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rocket Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rocket Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RCKT Stock Alerts